Drug Shortage Report for MAR-ATORVASTATIN

Last updated on 2021-03-09 History
Report ID 127855
Drug Identification Number 02454025
Brand name MAR-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MARCAN PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500 TABLET
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-11-06
Actual start date 2020-11-06
Estimated end date 2021-03-08
Actual end date 2021-03-08
Shortage status Resolved
Updated date 2021-03-09
Company comments Business reasons
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-03-09 English Compare
v5 2021-03-08 French Compare
v4 2021-03-08 English Compare
v3 2020-11-07 English Compare
v2 2020-11-06 French Compare
v1 2020-11-06 English Compare

Showing 1 to 6 of 6